Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 11/20 | 0.40 |
| ▸ | CA2 | P00918 | 11/20 | 0.40 |
| ▸ | CA12 | O43570 | 6/20 | 0.40 |
| ▸ | CA9 | Q16790 | 6/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17175570 | 0.94 | MEN1 (0.55) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL11990363 | 0.93 | MEN1 (0.44) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL17972765 | 0.93 | TDP1 (0.51) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL12432862 | 0.92 | MAOA (0.45) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL19050938 | 0.90 | TDP1 (0.55) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL17175287 | 0.88 | MEN1 (0.47) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL19416426 | 0.87 | MAOA (0.45) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL17972782 | 0.87 | MEN1 (0.41) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL15739536 | 0.87 | MEN1 (0.41) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL15716848 | 0.85 | MEN1 (0.41) | MEN1KMT2AGAATDP1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691997-B2 | Macrocycles | LUMIPHORE, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-11691997-B2 | Macrocycles | LUMIPHORE, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-11453652-B2 | Di-macrocycles | LUMIPHORE, INC. (US) | 2022-09-27 | — | — | US | disclosed |
| EP-3129350-B1 | MACROCYCLES | LUMIPHORE INC (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-2051968-B1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | UNIV CALIFORNIA (US) | 2020-04-29 | — | — | EP | disclosed |
| EP-2920157-B1 | DI-MACROCYCLES | LUMIPHORE INC (US) | 2019-09-11 | — | — | EP | disclosed |
| EP-2920157-B1 | DI-MACROCYCLES | LUMIPHORE INC (US) | 2019-09-11 | — | — | EP | disclosed |
| EP-2511266-B1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | UNIV CALIFORNIA (US) | 2019-09-04 | — | — | EP | disclosed |
| US-10273256-B2 | Macrocycles | LUMIPHORE, INC. (US) | 2019-04-30 | — | — | US | disclosed |
| EP-3263562-A1 | RADIOPHARMACEUTICAL COMPLEXES | Lumiphore, Inc. (US) | 2018-01-03 | — | — | EP | disclosed |
| US-20100167289-A1 | MULTI-COLOR TIME RESOLVED FLUOROPHORES BASED ON MACROCYCLIC LANTHANIDE COMPLEXES | LUMIPHORE, INC. | 2010-07-01 | — | — | US | disclosed |
| US-20100167289-A1 | MULTI-COLOR TIME RESOLVED FLUOROPHORES BASED ON MACROCYCLIC LANTHANIDE COMPLEXES | LUMIPHORE, INC. | 2010-07-01 | — | — | US | disclosed |
| US-20100015725-A1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-01-21 | — | — | US | disclosed |
| EP-2044090-A2 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-04-08 | — | — | EP | disclosed |
| US-20080213780-A1 | Hydroxy-isophthalamide moieties bind antigens/proteins; high stability as well and quantum yields of luminescence in aqueous media without the need for secondary activating agents | LUMIPHORE, INC. (US) | 2008-09-04 | — | — | US | disclosed |
| US-20080213780-A1 | Hydroxy-isophthalamide moieties bind antigens/proteins; high stability as well and quantum yields of luminescence in aqueous media without the need for secondary activating agents | LUMIPHORE, INC. (US) | 2008-09-04 | — | — | US | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| WO-2008092120-A1 | MULTI-COLOR TIME RESOLVED FLUOROPHORES BASED ON MACROCYCLIC LANTHANIDE COMPLEXES | LUMIPHORE, INC. (US) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008008797-A2 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | SSB, HACD3, CLTA | MEN1 1772/4885KMT2A 3655/4885GAA 1305/4885 |
| US-11691997-B2 | Macrocycles | HCCS, ABCB7, AURKAIP1 | MEN1 377/4885KMT2A 4535/4885GAA 2085/4885 |
| US-11453652-B2 | Di-macrocycles | DLD, NDC1, MCL1 | MEN1 220/4885KMT2A 4469/4885GAA 2024/4885 |
| US-10273256-B2 | Macrocycles | HCCS, ABCB7, AURKAIP1 | MEN1 377/4885KMT2A 4535/4885GAA 2085/4885 |
| US-20100167289-A1 | MULTI-COLOR TIME RESOLVED FLUOROPHORES BASED ON MACROCYCLIC LANTHANIDE COMPLEXES | HACD3, CLTA, HDHD5 | MEN1 2484/4885KMT2A 1464/4885GAA 1097/4885 |
| US-20080213780-A1 | Hydroxy-isophthalamide moieties bind antigens/proteins; high stability as well and quantum yields of luminescence in aqueous media without the need for secondary activating agents | LY96, SSB, UACA | MEN1 2593/4885KMT2A 2534/4885GAA 1089/4885 |
| US-20100015725-A1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | PLPBP, HPD, LASP1 | MEN1 1167/4885KMT2A 3670/4885GAA 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.